DZD8586 Combination Therapy in Patients With Diffuse Large B-cell Lymphoma (TAI-SHAN12)

Clinical trial NCT07059650 · RECRUITING

Trial details

NCT number: NCT07059650
Sponsor: Dizal Pharmaceuticals
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Diffuse Large B-Cell Lymphoma

Start date: 2025-08-19
Primary completion: 2030-10-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.